:: Volume 19, Issue 1 (Bimonthly 2015) ::
Feyz 2015, 19(1): 1-7 Back to browse issues page
The effect of metformin on memory retention of inhibitory avoidance learning in streptozotocin-induced rat model of alzheimer’s disease
Mohammad Hosein Esmaeili *, Mahin Mafe-Esmaeili
Qazvine University of Medical Sciences , esmail66@yahoo.com
Abstract:   (3272 Views)
Background: Alzheimer’s disease (AD) is closely associated with impaired insulin signaling in brain, suggesting it to be a brain-specific form of diabetes and thus termed as the “type 3 diabetes”. Metformin is one of the most widely used agent against insulin resistance. The present study aimed to investigate the therapeutic effect of metformin on memory retention in streptozotocin (STZ)-induced model of AD in rats using an inhibitory avoidance learning.
Materials and Methods: In this experimental study, 56 male Wistar rats were randomly allocated into 7 groups: control STZ-treated, STZ plus saline or metformin. For the induction of AD, STZ (3 mg/kg) was administered bilaterally into lateral ventricles. All rats were trained in shuttle box for inhibitory avoidance learning. Metformin (50, 100, 200 mg/kg, i.p) or saline were injected immediately after the training. The retention test was performed after two days.
Results: The results showed that post-training injection of metformin dose-dependently increased the time spent in the light chamber before entering to the dark chamber in STZ-treated rats. Moreover, metformin dose-dependently improved the memory retention in the rats.
Conclusion: Post-training injection of metformin dose-dependently enhanced the memory retention in STZ-induced model of AD.
Keywords: Alzheimer, Metformin, Inhibitory avoidance learning, Memory
Full-Text [PDF 307 kb]   (1077 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2015/02/24 | Accepted: 2015/02/24 | Published: 2015/02/24


XML   Persian Abstract   Print



Volume 19, Issue 1 (Bimonthly 2015) Back to browse issues page